Tisch MS News

Dr. Jamie Wong and Dr. Saud Sadiq Featured in BioSpace

Our recent research paper on the potential causes of sporadic ALS (sALS) was featured in an article in BioSpace. The piece quotes Tisch MSRCNY Director and Chief Research Scientist Dr. Saud A. Sadiq, and Tisch research scientist Dr. Jamie Wong, the lead author of the research paper. The article...

September 9, 2022

More

Tisch MSRCNY Research Scientist Featured in Managed Healthcare Executive

Tisch MSRCNY research scientist Dr. Roberto Alfonso, and his recent research paper around COVID-19 vaccines, were featured in an article in Managed Healthcare Executive. In the piece, Dr. Alfonso highlights the significance of the research findings, which suggest that MS patients receiving anti-...

September 7, 2022

More

Tisch MSRCNY Research featured in ALS News Today

The Tisch MSRCNY – and our recent research around the potential causes of sporadic ALS (sALS), using our novel animal model – have been featured in an article in ALS News Today. Based on our research, which was recently published in Brain Communications , this piece in ALS News Today highlights the...

August 31, 2022

More

Tisch MSRCNY Research Scientist, Dr. Roberto Alfonso featured in RealTalk MS Podcast

Tisch MSRCNY research scientist Dr. Roberto Alfonso has been featured on an episode of Real Talk MS podcast about our recent research paper around COVID-19 vaccines, on which he was the lead author and which was published in the journal Frontiers in Immunology . This study’s findings – which showed...

August 31, 2022

More

Tisch MSRCNY Research Published in Brain Communications

The Larry G. Gluck Division of ALS Research located at the Tisch MS Research Center of New York has published research in Brain Communications . In this study, Tisch researchers developed a first-of-its-kind cerebrospinal fluid-mediated mouse model to identify apolipoprotein B-100 (ApoB) as a key...

August 22, 2022

More

Tisch MSRCNY Research Published in Frontiers in Immunology

The paper shows that MS patients receiving anti-CD20 therapy saw strong T-cell activation in response to receiving the COVID-19 vaccination, even in conditions of deficient antibody production. Furthermore, our research found no difference in patients’ T-cell response regardless of form of the...

August 8, 2022

More

Development Coordinator ~ Tisch MSRCNY is Hiring!

Development Coordinator – Tisch MS Research Center of New York THIS IS NOT A REMOTE POSITION. ALL APPLICANTS MUST BE ABLE TO PHYSICALLY WORK AT OUR OFFICES IN MIDTOWN WEST MANHATTAN. Job Summary: The Development Coordinator will play a key role in a two-person development team to coordinate and...

January 11, 2022

More

Journal Club 7/22/22

Last week our researchers and physicians discussed a paper about the identification of anti-oligodendrocyte antibodies and their implications in MSdisease pathology. MSis an autoimmune disease characterized by damage to the Central Nervous System (CNS), specifically to myelin sheaths and...

July 27, 2022

More

Tisch MSRCNY featured in Managed Healthcare Executive

Tisch MSRCNY and Dr. Violaine Harris have been featured in an article in Managed Healthcare Executive about the preliminary analysis of results from our FDA-approved stem cell treatment study. The Q&A highlights the impact of our stem cell research, in particular the potential of our biomarker...

July 13, 2022

More

Dr. Sadiq Featured in RealTalk MS Podcast

During the interview, Dr. Sadiq discusses the preliminary analysis of results from our FDA-approved stem cell treatment study and the exciting implications they could have for MS treatment moving forward. He also gives listeners further background on our center and some of the other groundbreaking...

June 29, 2022

More

Pages

News Archive

Pages

Tisch MS Research Center of New York

521 West 57th Street
4th Floor
New York, NY 10019
(646) 557-3900

Privacy Policy

 

Support Tisch MS

Support Tisch MS and our innovative research leading to treatments that improve the lives of patients.